comparemela.com

Latest Breaking News On - Marks george - Page 1 : comparemela.com

Neuromodulation Trial for TRD Shows the Value of Tailored Tx

Intermittent theta burst stimulation for refractory depression failed to outperform rTMS. Nevertheless, the results are valuable because they show the potential merit of an individualized approach.

Richard-morriss
Marks-george
More-research
University-of-nottingham-united-kingdom
University-of-south-carolina
United-kingdom
Medscape-medical
Hamilton-depression-rating-scale
Medical-university
South-carolina
Brain-stimulation
Depression

Investing in Modern and Advanced Treatment Devices to Help Treatment-Resistant Patient Populations

It is time for the mental health industry to embrace modern and advanced technology to help treatment-resistant patients.

Anthony-barker
Marks-george
Aaron-tendler
Chief-medical-officer
Deep-transcranial-magnetic-stimulation

MAPS PBC Announces Frontiers in Psychiatry Published First Study to Evaluate Neural Impact of MDMA-Assisted Therapy in Patients with PTSD

/PRNewswire/ MAPS Public Benefit Corporation ("MAPS PBC"), a private biopharmaceutical company dedicated to the development and commercialization of.

United-states
Americans
Marks-george
Amy-emerson
Va-national-center
Multidisciplinary-association-for-psychedelic
University-of-south-carolina
Drug-administration
Public-benefit-corporation
Benefit-corporation
Distinguished-professor
Medical-university

MAPS PBC Announces Frontiers in Psychiatry Published First Study to Evaluate Neural Impact of MDMA-Assisted Therapy in Patients with PTSD

MAPS PBC Announces Frontiers in Psychiatry Published First Study to Evaluate Neural Impact of MDMA-Assisted Therapy in Patients with PTSD - read this article along with other careers information, tips and advice on BioSpace

United-states
Americans
Marks-george
Amy-emerson
Public-benefit-corp
Va-national-center
Multidisciplinary-association-for-psychedelic
University-of-south-carolina
Drug-administration
Public-benefit-corporation
Benefit-corp
Distinguished-professor

FDA Clears SAINT Neuromodulation System for Major Depressive Disorder

The FDA has cleared the SAINT Neuromodulation System for the treatment of MDD in adults who have failed prior antidepressant medications.

Marks-george
Brain-stimulation-division
University-of-south-carolina
Drug-administration
Neuromodulation-system
Depression-rating-scale
Medical-university

vimarsana © 2020. All Rights Reserved.